Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | P2RX4 | Q99571 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | SCN4A | P35499 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20495320 | 0.85 | P2RX4 (0.35) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL23356595 | 0.82 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL29657186 | 0.81 | P2RX4 (0.38) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL4595897 | 0.72 | KMT2A (0.47) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL26629588 | 0.70 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL11792980 | 0.70 | SMN1; SMN2 (0.46) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL3625895 | 0.70 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| Iodide SCHEMBL27570286 | 0.70 | KMT2A (0.46) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL7528724 | 0.70 | SMN1; SMN2 (0.59) | SMN1; SMN2LMNAP2RX4MEN1KMT2A | |
| SCHEMBL10824458 | 0.69 | MEN1 (0.46) | SMN1; SMN2LMNAP2RX4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | SMN1; SMN2 4079/4885LMNA 1721/4885P2RX4 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.